Blue Prism announced that Dr. Jason Kingdon has re-assumed the role of full-time Executive Chairman, a role he previously held prior to the Company's highly successful IPO in 2016, to accelerate Blue Prism's role as a platform for corporate adoption of Artificial Intelligence (AI) technologies. Dr. Kingdon has been engaged with Blue Prism for over 11 years and has an unparalleled understanding of the product, its underlying technology, and the Group's ongoing strategic direction. As Executive Chairman Dr. Kingdon will assume direct reporting and leadership responsibility for Blue Prism's go-to-market and product functions. Alastair Bathgate will remain Chief Executive Officer and will focus the majority of his time on customer relationships, promotion of the Blue Prism brand and various strategic programmes. These responsibilities increasingly require dedicated and expert attention given the Group's rapid global growth and the increasing opportunities within the Group's existing customer base of over 1,400 (at 30 April 2019 and adjusted for the Thoughtonomy acquisition). Kingdon and Bathgate will share responsibility for Investor Relations. These changes to the structure will become effective immediately. With these changes the Board will have half its members as independent Non-Executive Directors. Further to ensure appropriate governance, Chris Batterham will assume the role of Non-Executive Deputy Chairman and remain as Senior Independent Director of the Group.